Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W6HI
|
|||
Former ID |
DIB019594
|
|||
Drug Name |
PMID24775305C7u
|
|||
Synonyms |
GTPL8633; BDBM50015362
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C25H28N4O5
|
|||
Canonical SMILES |
CCOC1=CC=CC(=C1)C2=CC=C(C=C2)COC(=O)N3CCCC3C(=O)NC(CC(=O)N)C#N
|
|||
InChI |
1S/C25H28N4O5/c1-2-33-21-6-3-5-19(13-21)18-10-8-17(9-11-18)16-34-25(32)29-12-4-7-22(29)24(31)28-20(15-26)14-23(27)30/h3,5-6,8-11,13,20,22H,2,4,7,12,14,16H2,1H3,(H2,27,30)(H,28,31)/t20-,22-/m0/s1
|
|||
InChIKey |
BZVXYJWEOARYIS-UNMCSNQZSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Legumain (LGMN) | Target Info | Inhibitor | [1] |
KEGG Pathway | Lysosome | |||
Antigen processing and presentation | ||||
Reactome | Trafficking and processing of endosomal TLR | |||
Vitamin D (calciferol) metabolism | ||||
MHC class II antigen presentation | ||||
WikiPathways | Metabolism of steroid hormones and vitamin D | |||
MHC class II antigen presentation |
References | Top | |||
---|---|---|---|---|
REF 1 | P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. Bioorg Med Chem Lett. 2014 Jun 1;24(11):2521-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.